Drug intelligence / Profile preview

bis(N-maleimidomethyl)ether

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Bis(N-maleimidomethyl)ether is a synthetic small molecule crosslinking reagent belonging to the maleimide class of organic compounds. It contains two reactive maleimide groups connected by an ether-linked methylene bridge. This compound is primarily used as a homobifunctional sulfhydryl-reactive crosslinker in biochemical and chemical synthesis applications, including peptide and protein modification and the synthesis of DNA/RNA conjugates. In experimental research, it has been shown to covalently modify hemoglobin at specific cysteine and histidine residues, stabilizing hemoglobin structure and preventing sickling in red blood cells—a property investigated for potential antisickling therapy in sickle cell disease[8]. The compound acts as an electron acceptor capable of forming stable covalent bonds with thiol-containing biomolecules[5][8].

Other names
bis-maleimidomethyletherN,N'-(Oxydimethylene)dimaleimide1,1'-(Oxybis(methylene))bis(1H-pyrrole-2,5-dione)α,α'-(Bismaleimido)dimethyl etherBMME
02

Targets

Hb (Hemoglobin)

Beyond the preview

Go deeper on bis(N-maleimidomethyl)ether.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bis(N-maleimidomethyl)ether.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call